Astec Lifesciences is currently trading at its upper circuit limit of Rs. 32.40, up by 1.50 points or 4.85% from its previous closing of Rs. 30.90 on the BSE.
The scrip opened at Rs. 32.35 and has touched a high and low of Rs. 32.40 and Rs. 32.35 respectively. So far 4285 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 61.70 on 18-Apr-2011 and a 52 week low of Rs. 21.05 on 22-Dec-2011.
Last one week high and low of the scrip stood at Rs. 32.40 and Rs. 28.70 respectively. The current market cap of the company is Rs. 54.85 crore.
The promoters holding in the company stood at 55.70% while Non-Institutions held 44.30% stake in the company.
Astec Lifesciences has entered into an exclusive long term contract with a multinational company (MNC) to manufacture and supply a fungicide. The said project will come up at company's new site at Mahad in the state of Maharashtra.
Further, the company expects this development to contribute significantly to growth in terms of sales and profitability.
Astec LifeSciences is a producer of agrochemicals and pharmaceutical intermediates. The company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates.
Company Name | CMP |
---|---|
UPL | 568.30 |
BASF India | 5718.70 |
PI Industries | 4121.30 |
Bayer CropScience | 5776.95 |
Sumitomo Chemical India | 514.15 |
View more.. |